Guest Host: Steve Roberts

For years, Republican members of Congress stymied President Clinton’s attempts to appoint federal judges. Today some GOP representatives want to change the procedure for appointing judges so that Democrats can’t return the favor. A panel talks about the politics of filling vacancies on the federal bench, and how it’s affecting the judicial system.


  • Clint Bolick Vice President of the Institute for Justice
  • Nan Aron president of the Alliance for Justice
  • Joan Biskupic Supreme Court reporter, "USA Today;" author, "Sandra Day O'Connor: How the First Woman on the Supreme Court Became Its Most Influential Justice;" now working on a biography about Justice Antonin Scalia.

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 02 2015Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 02 2015Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.

Steven Lee Myers: “The New Tsar”

Thursday, Oct 01 2015Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.

The Debate Over Drug Pricing

Thursday, Oct 01 2015The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.